Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Swixx Biopharma (Group)

Swixx operates fully owned subsidiaries across Central and Eastern Europe, Greece, and Russia. With 600 employees and sales exceeding €260 million in 2021, Swixx has swiftly evolved into the largest and fastest-growing dedicated commercialization platform for biopharma and self-medication innovative companies in CEE. The company has gathered outstanding rare disease, oncology-haematology, specialty, and self-medication talent under one roof. *


Period Start 2014-12-01 established
  Predecessor PharmaSwiss (Group)
Product Industry pharmaceutical
Region Region Baar ZG
  Country Switzerland
  Street 5A Neuhofstr.
  City 6340 Baar ZG
  Tel +41-41-5523-440
    Address record changed: 2021-05-28
Basic data Employees n. a.
    * Document for �About Section�: Swixx Biopharma AG. (5/20/21). "Press Release: Swixx Welcomes Mérieux Equity Partners as Minority Shareholder and Announces €45 Million Capital Increase". Baar.
Record changed: 2021-05-28


Picture [iito] Made Without Love 650x80px

More documents for Swixx Biopharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top